Seller record · Telehealth service

Nucific

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The home and terms refer to licensed U.S. pharmacy partners without identifying a dispensing pharmacy by name. 1 more criterion also fails; see the table below.

At a glance

NucificTelehealth service

5/8criteria passed

Price: Compounded semaglutide from $117 a month; compounded tirzepatide from $139 a month
Sells: compounded semaglutide, compounded tirzepatide, Zepbound, and 1 more
FDA letters: None on file

Visit Nucific See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A supplement storefront that also offers compounded and brand-name GLP-1 treatment through OpenLoop clinicians, with medication included in its treatment programs.

Operating entity Pacific Health Supplements, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Nucific's website
S2	Prescription gating	NOT VERIFIED	Nucific's website; Nucific's terms of service page
S3	Pharmacy identification	FAIL	Nucific's website; Nucific's terms of service page
S4	Compounding disclosure	PASS	Nucific's website
S5	Analytical documentation	FAIL	Nucific's website
S6	Business address	PASS	Nucific's terms of service page
S7	Price disclosure	PASS	Nucific's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe medical disclosure identifies OpenLoop Health and U.S.-licensed clinicians who independently review medical history and determine whether to prescribe.Source: Nucific's website.

S2NOT VERIFIEDThe public payment-versus-assessment sequence did not resolve, because the home describes an assessment followed by clinician review while the terms describe refund after a decline, without specifying when payment is collected relative to the medical questionnaire. The check is open.Source: Nucific's website; Nucific's terms of service page.

S3FAILThe home and terms refer to licensed U.S. pharmacy partners without identifying a dispensing pharmacy by name.Source: Nucific's website; Nucific's terms of service page.

S4PASSHome and terms explicitly state compounded products are not FDA-approved and have not been evaluated by FDA for safety, effectiveness or quality.Source: Nucific's website.

S5FAILNo lot-specific certificate or batch document appears in the homepage, contact, returns, about, terms and privacy pages examined.Source: Nucific's website.

S6PASSThe terms identify Pacific Health Supplements, LLC and give 19528 Ventura Blvd, Suite 343, Tarzana, CA 91356 as the mailing address.Source: Nucific's terms of service page.

S7PASSHome prints compounded semaglutide from $117/month and compounded tirzepatide from $139/month; terms say medication costs are included in the program. These are starting prices, not a universal all-dose quote.Source: Nucific's website.

S8PASSNo FDA warning letter names Pacific Health Supplements, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, Zepbound, Ozempic.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Nucific

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.